Growth N. V. Biotech

CIK: 0001259869

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)11 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

BDTX

Black Diamond Therapeutics, Inc.

10% Owner

EPIX

ESSA Pharma Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (11 total)

BDTX
Black Diamond Therapeutics, Inc.
Mar 19, 2025
Sale(S)
Direct
1M shares at avg. $2.07$2.1M
BDTX
Black Diamond Therapeutics, Inc.
Mar 19, 2025
Sale(S)
Direct
300K shares at avg. $1.94$583K
BDTX
Black Diamond Therapeutics, Inc.
Mar 19, 2025
Sale(S)
Direct
1M shares at avg. $2.31$2.3M
BDTX
Black Diamond Therapeutics, Inc.
Mar 19, 2025
Sale(S)
Direct
2M shares at avg. $2.00$4.0M
BDTX
Black Diamond Therapeutics, Inc.
Mar 19, 2025
Sale(S)
Direct
400K shares at avg. $2.09$837K
BDTX
Black Diamond Therapeutics, Inc.
Mar 19, 2025
Sale(S)
Direct
584.3K shares at avg. $1.95$1.1M
BDTX
Black Diamond Therapeutics, Inc.
Mar 19, 2025
Sale(S)
Direct
500K shares at avg. $2.12$1.1M
EPIX
ESSA Pharma Inc.
Nov 1, 2024
Sale(S)
Direct
2M shares at avg. $1.53$3.1M
EPIX
ESSA Pharma Inc.
Nov 1, 2024
Sale(S)
Direct
2M shares at avg. $1.53$3.1M
EPIX
ESSA Pharma Inc.
Nov 1, 2024
Sale(S)
Direct
2M shares at avg. $1.53$3.1M
EPIX
ESSA Pharma Inc.
Nov 1, 2024
Sale(S)
Direct
1.9M shares at avg. $1.51$2.8M

		Type	Shares	Price		Ownership
Mar 19, 2025	BDTX Black Diamond Therapeutics, Inc.	Sale(S)	1,000,000	$2.07	$2,069,100	Direct
Mar 19, 2025	BDTX Black Diamond Therapeutics, Inc.	Sale(S)	300,000	$1.94	$582,900	Direct
Mar 19, 2025	BDTX Black Diamond Therapeutics, Inc.	Sale(S)	1,000,000	$2.31	$2,308,100	Direct
Mar 19, 2025	BDTX Black Diamond Therapeutics, Inc.	Sale(S)	2,000,000	$2.00	$4,000,800	Direct
Mar 19, 2025	BDTX Black Diamond Therapeutics, Inc.	Sale(S)	400,000	$2.09	$837,160	Direct
Mar 19, 2025	BDTX Black Diamond Therapeutics, Inc.	Sale(S)	584,292	$1.95	$1,141,239	Direct
Mar 19, 2025	BDTX Black Diamond Therapeutics, Inc.	Sale(S)	500,000	$2.12	$1,058,450	Direct
Nov 1, 2024	EPIX ESSA Pharma Inc.	Sale(S)	2,000,000	$1.53	$3,064,000	Direct
Nov 1, 2024	EPIX ESSA Pharma Inc.	Sale(S)	2,000,000	$1.53	$3,051,800	Direct
Nov 1, 2024	EPIX ESSA Pharma Inc.	Sale(S)	2,000,000	$1.53	$3,058,800	Direct
Nov 1, 2024	EPIX ESSA Pharma Inc.	Sale(S)	1,879,583	$1.51	$2,843,809	Direct

1-11 of 11 transactions

About BIOTECH GROWTH N V

BIOTECH GROWTH N V (SEC CIK 0001259869) files insider reports with the SEC as 10% Owner of Black Diamond Therapeutics, Inc. (BDTX) and 10% Owner of ESSA Pharma Inc. (EPIX).

Signal8 holds 2 ownership filings by BIOTECH GROWTH N V, all Form 4s, filed between Nov 5, 2024 and Mar 20, 2025. Those filings report 11 transactions, from Nov 1, 2024 to Mar 19, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on BIOTECH GROWTH N V's filings is in CURACAO, P8.

Recent filings by BIOTECH GROWTH N V

Mar 19, 2025: Open-market sales of BDTX shares (7 lines, Form 4, code S).
Nov 1, 2024: Open-market sales of EPIX shares (4 lines, Form 4, code S).

Other insiders filing for Black Diamond Therapeutics, Inc. (BDTX)

Behbahani Ali, Director
Raman Prakash, Director
Kulkarni Samarth, Director
Menzel Garry E, Director
Dhingra Kapil, Director
Campbell Shannon, Director

How to read Form 4 transaction codes